Australia · Delayed Price · Currency is AUD IGO Limited Earnings Call Transcripts
Fiscal Year 2026
-
Record safety and productivity at Nova drove strong financials, while Greenbushes faced operational and safety challenges, leading to revised guidance and reduced CapEx. Group EBITDA reached AUD 119 million, with a net cash position of AUD 327 million.
-
Half-year results showed improved cost discipline and operational performance at Nova, while Greenbushes faced operational challenges but maintained strong margins. Revenue and EBITDA declined year-over-year, but cash flow and balance sheet remain robust, with a focus on disciplined capital allocation and growth at Greenbushes.
-
Strong operational and financial results were delivered, with Nova and Greenbushes driving positive cash flow and high margins. CGP3 ramp-up at Greenbushes is progressing, supporting further growth amid a buoyant lithium market.
-
Safety performance reached a record high, but Greenbushes production and revenue declined due to lower grades and weather. Free cash flow remained positive, and the balance sheet strengthened, with operational improvements at Kwinana and Nova offset by ongoing market and cost challenges.
Fiscal Year 2025
-
The AGM addressed a challenging year marked by significant impairments, a net loss, and strategic resets, but highlighted strong performance at Greenbushes and a renewed focus on battery materials. Board renewal, leadership changes, and a clear growth strategy to 2035 were emphasized.
-
Reported a $955 million net loss for FY 2025, driven by impairments and weak lithium/nickel prices. Greenbushes delivered strong cash flow and margins, while Kwinana was fully impaired. Focus remains on cost control, portfolio optimization, and prudent capital management.
-
Strong operational results at Nova and Greenbushes drove solid EBITDA and positive cash flow, despite ongoing challenges and a full impairment at Kwinana. Conservative guidance reflects market volatility, with a focus on prudent capital management and operational optimization.
-
Operational stability and strong cash generation at Greenbushes offset lower production and Kwinana challenges. CapEx guidance was revised down, exploration was reset, and the lithium market remains oversupplied with price pressure expected into next year.
-
Reported a net loss of AUD 782 million due to major impairments at Kwinana and exploration assets, with underlying losses reflecting weak lithium prices and operational challenges. Greenbushes delivered strong production and margins, while Nova and Forrestania faced headwinds. Focus remains on cost control, asset optimization, and strategic execution.
-
Greenbushes delivered strong production and margins, offsetting challenges at Kwinana and Nova, where impairments and market-driven inventory adjustments weighed on financials. Guidance for Kwinana and Nova will be updated as reviews conclude, with capital discipline and productivity remaining key priorities.
-
Greenbushes delivered strong production and cost performance, offsetting weaker nickel results as Nova faced lower grades and recoveries. No dividend was declared from TLEA, and cash flow was impacted by market conditions, but the company remains debt-free and focused on asset optimization.
Fiscal Year 2024
-
The meeting reviewed a year of significant change, with strong cash flow from Greenbushes and Nova supporting dividends despite market volatility. Leadership changes, a refreshed strategy, and operational challenges—especially at Kwinana—were discussed, with shareholders voicing concerns over board size, past acquisitions, and remuneration.
-
A refreshed 10-year strategy centers on battery materials, especially lithium, with disciplined diversification into copper and selective focus on nickel. Strong partnerships, cost competitiveness, and a robust balance sheet underpin patient growth, while culture, sustainability, and operational excellence are prioritized for long-term value.
-
FY24 saw strong cash generation, improved safety, and high-margin performance at Greenbushes, with AUD 319M NPAT and AUD 280M in dividends. Strategic focus remains on battery materials, with cost discipline and portfolio optimization amid market volatility.
-
Greenbushes returned to full production with strong margins and cash flow, while Kwinana and Nova showed operational improvements amid ongoing market volatility and portfolio rationalization. A major impairment was recognized in exploration, and a strategy refresh is underway.